The role of axillary lymph node dissection (ALND) has increasingly been called into question among patients with positive sentinel lymph nodes. Two recent trials have failed to show a survival difference in sentinel node-positive breast cancer patients who were randomized either to undergo completion ALND or not. | Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection The randomized controlled SENOMAC trial
